The combination of atorvastatin with Proanthocyanidin enhances antioxidant and reactive oxidative stress on HepG2 hepatocellular Carcinoma Cells.

T1107 polymer expressed potential anti-tumor effects against HepG2 cell line

In vitro antitumor efficacy of atorvastatin against acute monocytic leukemia cells

Biomolecular evaluation of apoptosis, cell cycle, oxidative stress, and limiting enzymes of the glycolytic pathway in hepatocellular carcinoma cell line HepG2 treated with crude

Phytochemical analysis and Antiproliferative activity of lotus peregrinus L. against MCF7 (breast carcinoma cell line)

Antitumor efficacy of atorvastatin in lung cancer mice model

Cytotoxic activity of some benzo[4,5]imidazo[1,2-a]pyrimidine derivatives against the human cancer cell lines HepG2 and MCF-7

A potential therapeutic impact of Gallic acid in a rat model of hepatocarcinogenesis through inhibition of cell proliferation and oncogenic miRNA-221 and induction of apoptosis b

Proanthocyanidin inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogensis model

Biochemical Evaluation of Antitumor Activity of Vitamin B17 Alone or in Combination with Platinum Based Drugs Against Ehrlich Ascites Carcinoma in Female Rats